Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro
Open Access
- 15 August 2000
- journal article
- Published by American Society of Hematology in Blood
- Vol. 96 (4) , 1327-1333
- https://doi.org/10.1182/blood.v96.4.1327
Abstract
Dendritic cells (DCs) genetically modified to continually express and present antigens may be potent physiologic adjuvants for induction of prophylacKeywords
This publication has 44 references indexed in Scilit:
- A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cellsNature, 2003
- Lentiviral Vectors--the Promise of Gene Therapy Within Reach?Science, 1999
- Dendritic cells generated from blood monocytes of HIV-1 patients are not infected and act as competent antigen presenting cells eliciting potent T-cell responsesImmunology Letters, 1999
- Transduction of human macrophages using a stable HIV-1/HIV-2-derived gene delivery systemGene Therapy, 1998
- Productive infection of dendritic cells by HIV-1 and their ability to capture virus are mediated through separate pathways.Journal of Clinical Investigation, 1997
- Multiply attenuated lentiviral vector achieves efficient gene delivery in vivoNature Biotechnology, 1997
- Generation of mature dendritic cells from human blood An improved method with special regard to clinical applicabilityJournal of Immunological Methods, 1996
- Protective immunity against HIV infection: has nature done the experiment for us?Immunology Today, 1996
- Langerhans cells and HIV infectionImmunology Today, 1995
- Phagocytosis: Flow Cytometric Quantitation with Fluorescent MicrospheresScience, 1982